Dr. Dzihan Abazovic

OVERVIEW

Džihan Abazović, MD is an emergency medicine specialist. He graduated from University of Belgrade Medical Faculty in 2007 and after graduation worked in the field of clinical genetics and intercellular signaling. In the years to follow he gained valuable knowledge in blood management.

He was head of emergency medicine department in the Emergency Medicine Centre of Montenegro in Ulcinj (2013-2018). Since 2010 Dr Abazovic has been working on a project at the Institute for Biochemistry and Molecular Biology. Along with his colleagues, Dr Abazovic was the first doctor in Serbia who introduced regenerative medicine in clinical practice.

Research of stem cell and blood derivatives in orthopedics and gynaecology are among his greatest interests and together with his teams he is introducing novel techniques in the treatment of different pathologies. He is the author of numerous publications and lecturer at numerous Congresses.

Renova clinic; Segova clinic Belgrade, Serbia; Imani Holistic Medical Center, Sofia, Bulgaria
Serbia
Contact for One on One clinical training
Scientific Board Member
Mail: [email protected]
Phone: +1 (954) 716-2140

WORK EXPERIENCE

Emergency medicine centre of Montenegro

Chief of department 2013

RENOVA clinic, Belgrade, Serbia

Consultant 2013

B.L.A & Co doo, Belgrade, Serbia

Medical director 2011

EDUCATION

Fellow, Department of Extra Corporeal Blood Management

Catharina hospital Eindhoven, The Netherlands I 2009

Medical License General medicine

Montenegro I 2011

Fellowship, Clinical genetics and intercellular signaling

Hospital das Clinicas, HCUFPR Curitiba, Brazil I 2008

PUBMED

Miljanovic D, Milicevic O, Loncar A, Abazovic D, Despot D, Banko A. The First Molecular Characterization of Serbian SARS-CoV-2 Isolates From a Unique Early Second Wave in Europe.

Front Microbiol. 2021 Jun 18;12:691154. doi: 10.3389/fmicb.2021.691154. PMID: 34220784; PMCID: PMC8250835.

Tinjić S, Abazović D, Ljubić D, Vojvodić D, Božanović T, Ibrišimović M, Marković S, Ljubić A. Influence of Autologous In Vitro Activation of Ovaries by Stem Cells and Growth Factors on Endocrine and Reproductive Function of Patients with Ovarian Insufficiency-A Clinical Trial Study.

Int J Fertil Steril. 2021 Jul;15(3):178-188. doi: 10.22074/IJFS.2020.134678. Epub 2021 Jun 22. PMID: 34155864; PMCID: PMC8233920.

Micovic S, Everts P, Calija B, Strugarevic E, Grubor N, Boricic M, Lesanovic J, Box H, Abazovic D. Novel autologous, high concentrated fibrin as advanced hemostatic agent for coronary surgery.

Transfus Apher Sci. 2021 Aug;60(4):103171. doi: 10.1016/j.transci.2021.103171. Epub 2021 May 27. PMID: 34099403.

PUBMED

Dulic O, Lalic I, Kecojevic V, Gavrilovic G, Abazovic D, Miskulin M, Maric D, Bumbasirevic M. Do knee injection portals affect clinical results of bone marrow aspirate concentrate injection in the treatment of osteoarthritis? A prospective randomized controlled study.

Regen Med. 2020 Aug;15(8):1987-2000. doi: 10.2217/rme-2020-0020. Epub 2020 Nov 5. PMID: 33151802.

Stefik D, Vranic V, Ivkovic N, Abazovic D, Maric D, Vojvodic D, Supic G. An insight into osteoarthritis susceptibility: Integration of immunological and genetic background.

Bosn J Basic Med Sci. 2021 Apr 1;21(2):155-162. doi: 10.17305/bjbms.2020.4735. PMID: 32937098; PMCID: PMC7982064.

Medenica S, Garalejic E, Arsic B, Medjo B, Bojovic Jovic D, Abazovic D, Vukovic R, Zarkovic M. Follicular fluid thyroid autoantibodies, thyrotropin, free thyroxine levels and assisted reproductive technology outcome.

PLoS One. 2018 Oct 29;13(10):e0206652. doi: 10.1371/journal.pone.0206652. PMID: 30372494; PMCID: PMC6205652.

Choose language »